Effect of growth hormone on intestinal Na+/glucose cotransporter activity

A. Tavakkolizadeh, K. R. Shen, J. Jasleen, D. I. Soybel, Danny Jacobs, M. J. Zinner, S. W. Ashley, E. E. Whang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Growth hormone (GH) has been used alone or as part of a defined regimen in the treatment of patients with short bowel syndrome; however its mode of action remains unclear. Growth hormone has been shown to increase amino acid, water, and electrolyte absorption from the small intestine. The acute effect of growth hormone on intestinal sugar transport has not been described previously. Methods: Mucosal preparations of rat jejunum were mounted in the Ussing chamber. Growth hormone (2 × 10-6 M or 8 × 10-6 M) or vehicle was added to the serosal chamber 1, 3, or 5 hours later. Twenty or 40 minutes after growth hormone addition, 30 mmol/L 3-O-methylglucose was added to both chambers, and the change in short-circuit current (ΔISC) was recorded. In separate experiments, tissues were pretreated with phloridzin, an inhibitor of Na+/glucose cotransport, before the addition of 3-O-methylglucose. In the final set of experiments, kinetic studies were performed. Results: GH did not induce any alterations in baseline electrical parameters. Only tissues left in the chambers for 5 hours, but not 1 or 3 hours, before GH treatment displayed a greater 3-O-methylglucose-induced ΔISC than controls (p < .05). The increase in ISC induced by 3-O-methylglucose was 100% phloridzin-inhibitable. Kinetic analysis showed that growth hormone administration is associated with an increase in Na+/glucose cotransporter maximal velocity (Vmax) but no significant change in carrier affinity for substrate (Km). Conclusions: Growth hormone increases intestinal sugar transport, but only in tissue that has not been exposed to endogenous GH for over 3 hours.

Original languageEnglish (US)
Pages (from-to)18-22
Number of pages5
JournalJournal of Parenteral and Enteral Nutrition
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Growth Hormone
Glucose
3-O-Methylglucose
Phlorhizin
Short Bowel Syndrome
Jejunum
Electrolytes
Small Intestine
Amino Acids
Water
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Tavakkolizadeh, A., Shen, K. R., Jasleen, J., Soybel, D. I., Jacobs, D., Zinner, M. J., ... Whang, E. E. (2001). Effect of growth hormone on intestinal Na+/glucose cotransporter activity. Journal of Parenteral and Enteral Nutrition, 25(1), 18-22. https://doi.org/10.1177/014860710102500118

Effect of growth hormone on intestinal Na+/glucose cotransporter activity. / Tavakkolizadeh, A.; Shen, K. R.; Jasleen, J.; Soybel, D. I.; Jacobs, Danny; Zinner, M. J.; Ashley, S. W.; Whang, E. E.

In: Journal of Parenteral and Enteral Nutrition, Vol. 25, No. 1, 01.01.2001, p. 18-22.

Research output: Contribution to journalArticle

Tavakkolizadeh, A, Shen, KR, Jasleen, J, Soybel, DI, Jacobs, D, Zinner, MJ, Ashley, SW & Whang, EE 2001, 'Effect of growth hormone on intestinal Na+/glucose cotransporter activity', Journal of Parenteral and Enteral Nutrition, vol. 25, no. 1, pp. 18-22. https://doi.org/10.1177/014860710102500118
Tavakkolizadeh, A. ; Shen, K. R. ; Jasleen, J. ; Soybel, D. I. ; Jacobs, Danny ; Zinner, M. J. ; Ashley, S. W. ; Whang, E. E. / Effect of growth hormone on intestinal Na+/glucose cotransporter activity. In: Journal of Parenteral and Enteral Nutrition. 2001 ; Vol. 25, No. 1. pp. 18-22.
@article{36d5fe039df146e4940592c51e910567,
title = "Effect of growth hormone on intestinal Na+/glucose cotransporter activity",
abstract = "Background: Growth hormone (GH) has been used alone or as part of a defined regimen in the treatment of patients with short bowel syndrome; however its mode of action remains unclear. Growth hormone has been shown to increase amino acid, water, and electrolyte absorption from the small intestine. The acute effect of growth hormone on intestinal sugar transport has not been described previously. Methods: Mucosal preparations of rat jejunum were mounted in the Ussing chamber. Growth hormone (2 × 10-6 M or 8 × 10-6 M) or vehicle was added to the serosal chamber 1, 3, or 5 hours later. Twenty or 40 minutes after growth hormone addition, 30 mmol/L 3-O-methylglucose was added to both chambers, and the change in short-circuit current (ΔISC) was recorded. In separate experiments, tissues were pretreated with phloridzin, an inhibitor of Na+/glucose cotransport, before the addition of 3-O-methylglucose. In the final set of experiments, kinetic studies were performed. Results: GH did not induce any alterations in baseline electrical parameters. Only tissues left in the chambers for 5 hours, but not 1 or 3 hours, before GH treatment displayed a greater 3-O-methylglucose-induced ΔISC than controls (p < .05). The increase in ISC induced by 3-O-methylglucose was 100{\%} phloridzin-inhibitable. Kinetic analysis showed that growth hormone administration is associated with an increase in Na+/glucose cotransporter maximal velocity (Vmax) but no significant change in carrier affinity for substrate (Km). Conclusions: Growth hormone increases intestinal sugar transport, but only in tissue that has not been exposed to endogenous GH for over 3 hours.",
author = "A. Tavakkolizadeh and Shen, {K. R.} and J. Jasleen and Soybel, {D. I.} and Danny Jacobs and Zinner, {M. J.} and Ashley, {S. W.} and Whang, {E. E.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1177/014860710102500118",
language = "English (US)",
volume = "25",
pages = "18--22",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of growth hormone on intestinal Na+/glucose cotransporter activity

AU - Tavakkolizadeh, A.

AU - Shen, K. R.

AU - Jasleen, J.

AU - Soybel, D. I.

AU - Jacobs, Danny

AU - Zinner, M. J.

AU - Ashley, S. W.

AU - Whang, E. E.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Background: Growth hormone (GH) has been used alone or as part of a defined regimen in the treatment of patients with short bowel syndrome; however its mode of action remains unclear. Growth hormone has been shown to increase amino acid, water, and electrolyte absorption from the small intestine. The acute effect of growth hormone on intestinal sugar transport has not been described previously. Methods: Mucosal preparations of rat jejunum were mounted in the Ussing chamber. Growth hormone (2 × 10-6 M or 8 × 10-6 M) or vehicle was added to the serosal chamber 1, 3, or 5 hours later. Twenty or 40 minutes after growth hormone addition, 30 mmol/L 3-O-methylglucose was added to both chambers, and the change in short-circuit current (ΔISC) was recorded. In separate experiments, tissues were pretreated with phloridzin, an inhibitor of Na+/glucose cotransport, before the addition of 3-O-methylglucose. In the final set of experiments, kinetic studies were performed. Results: GH did not induce any alterations in baseline electrical parameters. Only tissues left in the chambers for 5 hours, but not 1 or 3 hours, before GH treatment displayed a greater 3-O-methylglucose-induced ΔISC than controls (p < .05). The increase in ISC induced by 3-O-methylglucose was 100% phloridzin-inhibitable. Kinetic analysis showed that growth hormone administration is associated with an increase in Na+/glucose cotransporter maximal velocity (Vmax) but no significant change in carrier affinity for substrate (Km). Conclusions: Growth hormone increases intestinal sugar transport, but only in tissue that has not been exposed to endogenous GH for over 3 hours.

AB - Background: Growth hormone (GH) has been used alone or as part of a defined regimen in the treatment of patients with short bowel syndrome; however its mode of action remains unclear. Growth hormone has been shown to increase amino acid, water, and electrolyte absorption from the small intestine. The acute effect of growth hormone on intestinal sugar transport has not been described previously. Methods: Mucosal preparations of rat jejunum were mounted in the Ussing chamber. Growth hormone (2 × 10-6 M or 8 × 10-6 M) or vehicle was added to the serosal chamber 1, 3, or 5 hours later. Twenty or 40 minutes after growth hormone addition, 30 mmol/L 3-O-methylglucose was added to both chambers, and the change in short-circuit current (ΔISC) was recorded. In separate experiments, tissues were pretreated with phloridzin, an inhibitor of Na+/glucose cotransport, before the addition of 3-O-methylglucose. In the final set of experiments, kinetic studies were performed. Results: GH did not induce any alterations in baseline electrical parameters. Only tissues left in the chambers for 5 hours, but not 1 or 3 hours, before GH treatment displayed a greater 3-O-methylglucose-induced ΔISC than controls (p < .05). The increase in ISC induced by 3-O-methylglucose was 100% phloridzin-inhibitable. Kinetic analysis showed that growth hormone administration is associated with an increase in Na+/glucose cotransporter maximal velocity (Vmax) but no significant change in carrier affinity for substrate (Km). Conclusions: Growth hormone increases intestinal sugar transport, but only in tissue that has not been exposed to endogenous GH for over 3 hours.

UR - http://www.scopus.com/inward/record.url?scp=0035186358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035186358&partnerID=8YFLogxK

U2 - 10.1177/014860710102500118

DO - 10.1177/014860710102500118

M3 - Article

VL - 25

SP - 18

EP - 22

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 1

ER -